Moreover, PD participants who had higher total ESS scores (β = 0.001; P = 0.012) (Supplementary Table S8) or who were considered as EDS (β = 0.013; P = 0.007) (Fig. 5G) showed an increasing trend of serum NfL levels. The gene discussed is NEFL; the disease is Ehlers-Danlos syndrome.